Absorption kinetics of short- and intermediate-acting insulins after jet injection with Medi-Jector II. 1988

C M Houtzagers, and P A Berntzen, and H van der Stap, and R J Heine, and E A van der Veen
Department of Internal Medicine, Free University Hospital, Amsterdam, The Netherlands.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007336 Insulin, Isophane An intermediate-acting INSULIN preparation with onset time of 2 hours and duration of 24 hours. It is produced by crystallizing ZINC-insulin-PROTAMINES at neutral pH 7. Thus it is called neutral protamine Hagedorn for inventor Hans Christian Hagedorn. Insulin, NPH,Insulin, Protamine Zinc,Isophane Insulin, Regular,NPH Insulin,Neutral Protamine Hagedorn Insulin,Protamine Hagedorn Insulin,Hagedorn Insulin, Protamine,Isophane Insulin,Protamine Zinc Insulin,Regular Isophane Insulin,Zinc Insulin, Protamine
D008297 Male Males
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D049528 Insulin, Long-Acting Insulin formulations that contain substances that retard absorption thus extending the time period of action. Insulin, Semilente,Long-Acting Insulin,Insulin, Long Acting,Long Acting Insulin,Semilente Insulin

Related Publications

C M Houtzagers, and P A Berntzen, and H van der Stap, and R J Heine, and E A van der Veen
December 1984, Diabetologia,
C M Houtzagers, and P A Berntzen, and H van der Stap, and R J Heine, and E A van der Veen
January 1987, Diabetes research (Edinburgh, Scotland),
C M Houtzagers, and P A Berntzen, and H van der Stap, and R J Heine, and E A van der Veen
January 2002, Diabetes technology & therapeutics,
C M Houtzagers, and P A Berntzen, and H van der Stap, and R J Heine, and E A van der Veen
May 1994, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
C M Houtzagers, and P A Berntzen, and H van der Stap, and R J Heine, and E A van der Veen
May 1988, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
C M Houtzagers, and P A Berntzen, and H van der Stap, and R J Heine, and E A van der Veen
January 1985, The Netherlands journal of medicine,
C M Houtzagers, and P A Berntzen, and H van der Stap, and R J Heine, and E A van der Veen
January 1985, The Netherlands journal of medicine,
C M Houtzagers, and P A Berntzen, and H van der Stap, and R J Heine, and E A van der Veen
January 1986, Diabetes care,
C M Houtzagers, and P A Berntzen, and H van der Stap, and R J Heine, and E A van der Veen
March 1983, Archives of internal medicine,
C M Houtzagers, and P A Berntzen, and H van der Stap, and R J Heine, and E A van der Veen
September 1986, The American journal of medicine,
Copied contents to your clipboard!